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Pengenalpastian faktor-faktor  yang mempengaruhi kawalan 
tekanan darah dikalangan pesakit darah tinggi di Hospital 
Besar Pulau Pinang 
 
     Abstrak 
 
Matlamat rawatan hipertensi ialah untuk memulih kembali tekanan darah dan 
mencegah komplikasi kardiovaskular dan renal. Secara praktik, matlamat ini 
sukar dicapai seperti yang digambarkan oleh kajian-kajian di klinik masyarakat 
dan pesakit luar. Pengenalpastian faktor-faktor  berhubung dengan kawalan 
hipertensi adalah penting dalam rawatannya. Banyak kajian yang diterbitkan 
sehingga kini berfokuskan pesakit luar dengan hanya sebilangan kecil  
bertumpu pada pesakit yang masih dirawat. Tujuan kajian ini ialah untuk 
menyiasat keberkesanan kawalan hipertensi dikalangan pesakit yang 
dimasukkan ke Hospital Besar Pulau Pinang serta menentukan faktor-faktor 
yang  mempengaruhi kawalan hipertensi dikalangan pesakit berkenaan. Empat 
ratus orang pesakit hipertensi kronik yang dimasukkan ke wad perubatan dipilih 
berturut-turut menyertai kajian ini. Mereka di pantau sehingga hari mereka 
dibenarkan pulang. Bacaan tekanan darah diperolehi dari rekod kesihatan 
sewaktu kemasukkan dan secara harian sehingga pesakit dibenarkan pulang. 
Maklumat lain yang diambil termasuklah data demografik, keadaan morbiditi, 
kerosakan organ sasaran, faktor risiko kardiovaskular, dan rawatan 
antihipertensi. Statistik deskriptif digunakan bagi menentukan ciri-ciri pesakit. 
Ujian student-T and Chi square digunakan untuk membandingkan angkubah 
berterusan dan frekuensi peratusan angkubah nominal masing-masing. 
 xv
Regressi logistik digunapakai untuk menentukan  peramal kawalan hipertensi. 
Keputusan menunjukkan bahawa 48.5% pesakit adalah lelaki manakala umur 
min ialah 59 ± 11 tahun. 39.6% pesakit adalah berbangsa Melayu, 36% 
berbangsa Cina dan 24.5% berbangsa India. Majoriti pesakit sudah berkahwin 
(82.3%). Lebih daripada separuh pesakit (51.5%) menerima pendidikan sekolah 
rendah.  44.5% pesakit terdiri dari surirumah. Hipertensi baru didagnosa dalam 
5.5% pesakit manakala 4.8% pesakit menderita hipertensi kurang dari setahun. 
60% pesakit menderita hipertensi antara 1 hingga 10 tahun dan 23.8% 
mengalami hipertensi lebih dari 10 tahun sementara untuk 6% pesakit pula, 
jangkawaktu  hipertensi tidak diketahui. Lebih kurang 10% pesakit dimasukkan 
ke wad kurang dari 5 hari. Tekanan darah dapat dikawal dikalangan 24% 
pesakit semasa kemasukan dan 54% pesakit semasa pesakit dibenarkan 
pulang. Analisa multivariate pada kemasukkan menunjukkan bahawa peramal 
kawalan tekanan darah adalah penggunaan diuretik dan statin. Faktor yang 
dikenalpasti berkaitan dengan kurang kawalan tekanan darah  adalah bangsa 
Melayu, diabetes, penyakit serebrovaskular, retinopati dan bilangan ko-
morbiditi. Analisa Multivariate pada masa pulang menunjukkan bahawa peramal 
kawalan tekanan darah yang baik adalah diuretik dan perencat beta manakala 
peramal kurang kawalan tekanan darah ialah diabetes, penyakit ginjal kronik, 
nefropati diabetik, penyakit serebrovaskular dan bilangan ko-morbiditi. 
Keputusan-keputusan ini menunjukkan bahawa hipertensi yang tidak terkawal 
dikalangan pesakit hospital dan kawalan tekanan darah adalah lebih baik 
semasa pesakit dibenarkan pulang daripada semasa kemasukan. Wanita, 
berbangsa Melayu, pesakit dengan diabetes, penyakit renal dan strok lebih 
berkemungkinan mengalami kurang kawalan hipertensi .   
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Identification of factors affecting blood pressure control in 
patients admitted with hypertension in Penang General 
Hospital  
 Abstract  
 
The goal of treatment of hypertension is to normalize the blood pressure and to 
prevent cardiovascular and renal complication. This goal is difficult to achieve in 
practice as shown by studies in the community and outpatients clinics.  
Identification of factors related to hypertension control is important in treatment 
of hypertension. Many studies published so far were done in outpatients with 
few studies on inpatients. The aim of this study was to investigate the adequacy 
of hypertension control in patients admitted to Penang General Hospital and to 
determine factors affecting hypertension control among these patients. 
Four hundred consecutive hypertensive patients admitted in medical wards in 
Penang General Hospital were included in the study. They were followed until 
the day of discharge. Blood pressure readings were extracted from medical 
records on admission and daily until the day of discharge. Other informations 
taken were demographic data, comorbid conditions, target organ damage, 
cardiovascular risk factors and antihypertensive treatment. Descriptive statistic 
was used to determine patients characteristic. Parametric and non parametric 
tests were used when applicable.  Logistic regression was used to determine 
predictors of hypertension control. The results showed that 48.5% of the 
patients were male, the mean age was 59± 11 years, 39.6% were Malay, 36% 
were Chinese and 24.5% were Indian.  The majority of patients were married 
(82.3%). More than half of the patients (51.5%) received primary school 
education only. House wives represent 44.5% of the sample. Hypertension was 
 xvii
newly diagnosed in 5.5%, 4.75% had hypertension for less than 1 year, about 
60% had hypertension for 1 to 10 years and 6% unknown  23.75% had 
hypertension for more than 10 years. More than half of the patients (54%) were 
admitted for less than 5 days. Blood pressure was controlled in 24% on 
admission and in 54% of patients on discharge. Multivariate analysis on 
admission revealed that the predictors of BP control were the use of diuretics 
and statin.  Factors identified to be associated with poor blood pressure control 
were Malay, diabetes, cerebrovascular disease, retinopathy and number of 
comorbidities.  Multivariate analysis on discharge showed that the predictors of 
good BP control were diuretics and beta- blockers and the predictors of poor BP 
control were diabetes, chronic kidney disease, diabetic nephropathy, 
cerebrovascular disease and number of comorbidity. These results 
demonstrated that hypertension was poorly controlled among inpatients and 
that BP control was better on discharge than on admission. Malay, patients with 
diabetes, renal disease and cerebrovascular disease were more likely to have 
poor hypertension control.  
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 Introduction  
 
Hypertension is defined as a persistent systolic blood pressure reading (SBP) of 
140 mmHg or greater and or a diastolic blood pressure reading (DBP) of 90 
mmHg or greater and or taking of antihypertensive medication, (JNCVII, 2003). 
Hypertension is divided into two main categories i.e., essential hypertension 
and secondary hypertension. Essential hypertension occurs in 90% of the cases 
and has no identifiable causes, while secondary hypertension occurs in the 
remaining 10% of the cases and has identified causes.  
 
1.2 Classification of hypertension 
The seventh Report of The Joint National Committee on Prevention, Detection, 
Evaluation and Treatment of high blood pressure classified blood pressure into 
four categories namely , normal, prehypertension, stage one hypertension and 
stage two hypertension. The normal category  refers to blood pressure ranges 
of less than 120/80 mmHg, prehypertension is in the 120-139/80-89 mmHg 
range, stage one is 140-159/ 90-99 mmHg range and stage two is blood 
pressure equal to or more than 160/100 mmHg (JNCVII, 2003). This 
classification is based on average of two or more measurement on two or more 
office visits. Patients with prehypertension are at increased risk of progression 
to hypertension (JNCVII, 2003). They are twice more likely the risk to develop 
hypertension as those at a lower value (Vasan et al, 2001).   
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1.3 Prevalence of hypertension 
Hypertension affects about 1 billion individuals worldwide. In the United States 
the National Health and Nutrition Examination Survey (NHANES1988-2000) 
reported that hypertension prevalence was 31.3% with an estimates of 65 
million American having hypertension (Fields et al. 2004). Of hypertensive 
subjects 68.9% were found to be aware of their condition, 58.4% were on 
treatment and 31% had controlled their hypertension (Hajjar and Kotchen, 
2003).  
                                                                                                          
 In Malaysia, The National Health and Morbidity survey of 21,391 individuals 
over the age of 30 in 1996 showed a high prevalence of high blood pressure 
with 33% of adults having hypertension. Among hypertensive individuals, 33% 
were aware of their hypertension, 23% were on treatment while only 6% had 
controlled their hypertension (Lim et al, 2004). In China, the prevalence of 
hypertension was found to be 27.2% in the adult population aged between 35 to 
74 years of these 44.7% were aware of their condition, 28.2% were on 
treatment while only 8.1% had their blood pressure under control (Gu et al, 
2002). In a survey of rural Filipinos (age 30 and more), the prevalence of 
hypertension was found to be  23%, 42% were diagnosed, 47% were on 
treatment, while  blood pressure was controlled in 35% of the treated patients 
and in 17% of all hypertensive patients (Reyes-Gibby and Aday 2000). 
Awareness of hypertension is important to control blood pressure. Many 
patients are not aware of their condition leading to a low rate of hypertension 
control. In some communities about half of the patients were not aware of their 
condition. For instance, among the Parsi community of India, the prevalence of 
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hypertension was 36.4% of which 48.5% were not aware of their condition. 
Among those who were aware, 36.4% were not compliant and only 13.6% had 
controlled their hypertension (Bharucha and Kuruvilla 2003).                                                     
                                                                                                                       
Hypertension is a leading cause of morbidity and mortality with microvascular 
and macrovascular complication which includes coronary artery diseases, 
nephropathy, retinopathy, and neuropathy.  Hypertension is rarely present 
without other accompanying risk factors. There is a strong association between 
hypertension and diabetes mellitus, as many studies have reported a high 
prevalence of diabetes mellitus among hypertensive patients (Ghannem and 
Hadj, 1997, Gavalda et al, 1993, Mafauzy et al, 2003). Furthermore, a study 
conducted in a primary care clinic in Malaysia reported that 67% of patients with 
type 2 diabetic patients had hypertension (Chan, 2005).  
 
 A survey on the epidemiology of hypertension in Tunisia reported that 10.2% of 
the subjects were diabetic, 27.7% were obese, 56.7% were overweight and 
21.5% were smokers (Ghannem and Hadj, 1997). Another study on 
hypertensive patients in their first visit to a hypertension unit in Spain, showed 
that family history was present in 53%, a sedentary life style in 52%, high 
cholesterol levels in 37%, smoking in 35%, obesity in 33%, left ventricular 
hypertrophy in 16%, alcohol consumption in 13% and diabetes mellitus in 11% 
(Gavalda et al, 1993). In a study in Kelantan, hypertension was found to be 
associated with the high prevalence of diabetes mellitus (19%), obesity (39.4%) 
and hypercholesterolemia (70.7%) (Mafauzy et al, 2003).The presence of other 
risk factors affects the incidence of hypertension. In a longitudinal study in 
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Japan, 4857 normotensive subjects were followed up for two years from 1997 to 
1999 to determine the effect of the clustering of risk factors on blood pressure. It 
was found that a family history of hypertension, obesity, diabetes mellitus, 
hypercholesterolemia and hypertriglyceridemia were associated with the 
elevation of blood pressure and that the number of risk factors was positively 
associated with the increase in the level of both systolic and diastolic blood 
pressure (Tozawa et al, 2002). In a study in an urban health clinic in the Pacific 
Northwest, hypertensive patients were found to have diabetes mellitus, 
depression, heart disease and renal disease more than did non hypertensive 
patients (Rhoades et al, 2003).  
 
 1.4 Blood pressure control             
According to JNC VII Report (2003) and The Malaysian Clinical Practice 
Guidelines on the management of hypertension (2002) the goal of blood 
pressure is 140/90 mmHg for patients without diabetes mellitus and without 
kidney disease, 130/80 mmHg for patients with diabetes mellitus and 125/75 
mmHg for those with proteinuria of more than 1g/24 hours. Most patients need 
two or more antihypertensive drugs to achieve these goals (JNC VII, 2003). 
Blood pressure is considered controlled only when these goals are achieved.    
                                                                                                          
The goal of therapy is to normalize blood pressure and to prevent 
cardiovascular events. In clinical trials, antihypertensive therapy was associated 
with a 35% to 40% mean reduction in stroke incidence, a 20% to 25% reduction 
in myocardial infarction, and a more than 50% reduction in heart failure (Phillips 
et al 2001). However in clinical practice, blood pressure control is difficult to 
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achieve. National and international surveys continue to reveal that hypertension 
is under diagnosed, patients diagnosed are often not treated and those treated 
are often not satisfactorily controlled (Murlow, 1998). For example globally less 
than 30% of treated hypertensive achieves BP targets (Burt, et al, 1995). A 
study on hypertension in 9 primary health care centers in Bahrain found that of 
281 treated patients, only 16.5% had controlled blood pressure (Khaja et al, 
2003).  
 
Many studies have been conducted to identify the causes of uncontrolled blood 
pressure. It showed that many factors contribute to uncontrolled blood pressure. 
Most of these factors relate to the patients while others relate to health care 
providers. A Japanese survey on the impact of antihypertensive side effects 
found that 49% of patients with well controlled BP had at least one side effect 
with a current antihypertensive agent, whereas a significantly greater 
percentage of patients (61%) whose BP was poorly controlled tend to have a 
higher incidence of side effects (Toyoshima et al, 1997). The main cause of 
uncontrolled hypertension in many studies was the patient’s non compliance 
(Joshi et al 1996).                                                                                                                      
Non compliance and medication side effects were among patient’s factors that 
affect blood pressure control. These factors include factors that can be modified 
and that cannot be modified. Non modifiable factors include age, gender, 
ethnicity and family history. Modifiable factors include compliance, access to 
health care, and life style. Blood pressure control is also affected by physician 
factors. All these factors will be discussed in the following section. 
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1.5 Patient’s factors 
       1.5.1 Age  
The prevalence of hypertension increases with age as will the risk of 
cardiovascular disease. For individuals aged 40 to 70 years, each increment of 
20 mmHg in systolic BP or 10 mmHg in diastolic BP doubles the risk of 
cardiovascular disease across the entire BP range from 115/75 to 185/115 
mmHg. An individual who is normotensive at 55 years of age has a 90% risk for 
developing hypertension in his/her remaining lifetime (JNC VII Report, 2003). In 
cross-sectional and longitudinal population studies, systolic blood pressure 
increases until the age of 80 years while diastolic blood pressure increases only 
until 50 years old, then it either becomes constant or decreases slightly 
(Stasessen, et al, 2003). This is consistent with the data from a Malaysian 
survey in 1996 in which systolic blood pressure was found to increase with 
increasing age with diastolic blood pressure tending to decline beyond the age 
of 50-55 years (Lim, et al 2004). In the Framingham Heart Study, it was 
observed that the main predictor of cardiovascular risk changes from diastolic 
pressure to systolic pressure and then to pulse pressure with increasing age 
(Hyman and Pavlic, 2001). Below the age of 50, diastolic pressure was the 
strongest predictor. In contrast, between the  50-59 age group all three blood 
pressure indices were similar predictors, while from 60 years onwards, diastolic 
pressure was negatively related to the risk of coronary events, so that pulse 
pressure become a superior predictor compared to systolic pressure (The World 
Heath Report, 2002).    
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Hypertension occurs in more than two thirds of individual above 65 years 
(Hayman and Pavlic, 2001). However several randomized controlled trials 
showed that the treatment of hypertension in the elderly aged up to 84 years 
reduces stroke and cardiovascular morbidity and mortality (Kostis, et al 1997). 
Elderly patients are more susceptible to side effects than younger ones and the 
most common problem in the elderly is postural hypotension. As such, drug 
which may cause postural hypotension should be used with caution in this age 
group (National High Blood Pressure Education Program Working Group Report 
on Hypertension in elderly, 1994). The goal of treatment in older patients should 
be the same as in younger patients. In older patients an initial SBP below 160 
mmHg is acceptable and attempts should be made to reduce BP to target levels 
of less than /or equal to 140/90 mmHg (Whelton et al 1998). Lifestyle measures 
should be offered to all older patients and they are as effective in the elderly as 
in younger patients (Whelton et al 1998). Thiazide diuretics and dihydropyridine 
CCBs are especially effective at lowering BP in older patients (Staessen et al, 
1997). However, other drugs also have been shown to be effective (Wing, et al, 
2003).  From 65 years onwards it becomes more difficult to control blood 
pressure with treatment (Staessen, et al 1997) and many studies show that 
blood pressure control decreased with age (Lane et al, 2001 and Lloyd -Jones 
et al, 2005). In a study of hypertensive patients in Framingham Heart Study in 
1990, hypertension control rates among those younger than 60 years, those 
aged between 60 and 79 years and those aged 80 years and older were 38%, 
36% and 38% respectively  in men and 38%, 28% and 23% respectively in 
women (Lloyd-Jones et al, 2005). Even in compliant patients, blood pressure 
control was found to be difficult in old people and such control decreased with 
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aging. In a study of hypertensive compliant men who attended the Veterans 
Affair Centre, hypertension was controlled only in 34.8% of patients.  the rate of 
hypertension control in patients of  less than 60 years  was 42.1%, while for 
those  between 60 and 75 years, it was 33.7% and for those  older  than 75 
years, it  was 29.4%   (Bizien et al, 2004). Good hypertension control in primary 
care was associated with those aged 60 years and younger (Ornstein et al, 
2004). Systolic blood pressure is better controlled in younger than in older 
individuals, while diastolic blood pressure is better controlled in older patients 
(Ayodele et al, 2005, and Alexander et al 1999). In a retrospective study of 1700 
hypertensive patients in California, systolic blood pressure was controlled in 
40% of those younger than 65 years and only in 26% of those aged 65 years 
and older, while diastolic blood pressure was controlled in 63% of the younger 
group and in 83% of the older group (Alexander et al, 1999).    
                                                                                                                      
1.5.2 Gender  
The prevalence of hypertension is more common in men compared to women 
until the age of 55 years. With aging, it begins to shift. That is because female 
sex hormones offer cardiovascular protection. The loss of estrogen at 
menopause causes a more rapid increase over the time in systolic pressure in 
women than in men. In fact, pre menopausal women have lower systolic blood 
pressure than men, while diastolic blood pressure does not differ in either pre or 
post menopausal women. Before the age of 45, men have higher systolic blood 
pressure than women while after age of 45 years old, women have a higher 
systolic blood pressure (Ibrahim et al, 1995). In Malaysia, overall control of 
hypertension is low in women compared to men (Lim et al, 2004). Men tend to 
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have better control of systolic blood pressure, and combined blood pressure 
control and poorer control of diastolic blood pressure than women (Alexandar et 
al, 1999). However, other studies found that the male gender is associated with 
poor blood pressure control (Ibrahim et al, 1995).  
 
1.5.3 Ethnicity                                                                                                               
Most surveys showed that people of African origin have higher levels of blood 
pressure and a higher prevalence of hypertension than do those of white 
population (Primatista et al, 2000 and Cappuccio et al, 1997). They also have a 
higher rate of complications such as renal failure (Shulman et al, 1991) and left 
ventricular hypertrophy, (Kizer et al, 2004). A Black hypertensive is particularly 
sensitive to dietary salt restriction (Luft et al, 1991). They respond better to 
thiazide/ thiazide like diuretics or calcium channel blockers than to beta-
blockers (Materson et al, 1993) or ACE inhibitors (Brown, 2000 and Hansson et 
al, 2000). This is consistent with the finding from a study in Yale in which it was 
found that older black subjects respond better to diuretics and calcium channel 
blockers than to beta- blockers and ACE inhibitors, while white subjects 
especially younger individuals respond better to ACE inhibitors and beta- 
blockers. This difference in response disappears when a small amount of 
diuretics is added to other antihypertensive medication (Moser, 1995).                                      
Studies also show that British Asians have a higher mean blood pressure and 
hypertension prevalence than the white population (Primatesta et al, 2000, 
Cappuccio et al, 1997). They also have an increased risk of stroke and coronary 
heart disease (CHD) than the whites do (Cappuccio et al, 2002). In a study of 
hypertension in young adults in Singapore, Malays were found to have higher 
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prevalence of hypertension than Chinese and Indians (Gan et al, 2003) the 
same findings were also reported in Malaysia (Lim et al, 2004). In general blood 
pressure control in Malays was found to be lower (4%) compared to that in 
Chinese (7%) and Indians (9%) (Lim et al, 2004). 
  
 1.5.4 Diabetes Mellitus 
Hypertension commonly occurs in diabetic patients. It affects about 20-60% of 
patients with diabetes mellitus depending on obesity, ethnicity, and age. 
Hypertension in type 2 diabetes mellitus occurs as a part of metabolic 
syndrome. While, hypertension in type 1 diabetes mellitus usually reflects the 
presence of diabetic nephropathy (American Diabetes Association, 2004). In a 
study of hypertension in type 1 diabetes population compared to general 
population in US, individuals with type 1 diabetes mellitus had more 
hypertension (43% vs. 15%), albuminuria (13.6% vs. 2.2%) and 
macroalbuminuria (8.1% vs. 0.4%) than did non diabetic individuals (Maahs et 
al, 2005). The presence of hypertension increases the risk of morbidity and 
mortality. In type 1 diabetes mellitus, the incidence of hypertension increases 
with the increase in the duration of diabetes mellitus from 5% at 10 years to 
33% at 20 years and 70% at 40 years (Hypertension in Diabetic Study, 1993).  
Hypertension is more prevalent in type 2 diabetes mellitus. The Hypertension in 
Diabetic Study group report a 39% prevalence of hypertension among newly 
diagnosed patients, and, in approximately half of them, the elevated BP reflects 
the onset of microalbuminuria and was strongly associated with obesity 
(Hypertension in Diabetic Study, 1993 and National High Blood Pressure 
Program Working Group report on Hypertension in Diabetes Mellitus, 1994). 
 11
Numerous studies have cited the need for hypertension to be detected and 
treated early in diabetes mellitus to prevent cardiovascular disease and to delay 
the onset of diabetic nephropathy. In fact, it is recommended that the treatment 
of hypertension in diabetes mellitus should be started if blood pressure is equal 
to or more than 130/80 mmHg (JNCVII, 2003, Standard of Medical care for 
Patients with diabetes mellitus, 2002 and Malaysian Clinical Practice Guidelines 
on The Management of Hypertension 2002). The presence of microalbuminuria 
or overt proteinuria should be treated even if blood pressure is not elevated, 
(Malaysian Clinical Practice Guidelines on The Management of Hypertension, 
2002). In diabetic hypertensive patients, a lower target blood pressure is 
needed to get maximum reduction in development of cardiovascular and 
diabetic renal disease. The target of less than 130/80 mmHg is difficult to 
achieve but multiple drug prescription may assist in the attainment of this target 
(Bakris et al, 2000).   
                                                                                                                               
The choice of drugs should be individualized according to patient’s 
comorbidities. Diuretics, beta-blockers, calcium channel blockers, angiotensin 
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) 
can be used to achieve the target blood pressure. ACEIs are the drugs of 
choice due to their cardiovascular and renal protective effects in diabetic 
patients while in those who do not tolerate ACEIs, ARBs can be used (JNC VII, 
2003, Malaysian Clinical Practice Guidelines on the Management of     
Hypertension, 2002).                                                          
Diuretics can be used alone or in combination therapy. They should preferably 
be used with the lowest possible dose to minimize their metabolic side effects 
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which can be reduced when diuretics are used in combination with ACEIs or 
ARBs (Lind et al, 1994). Beta-blockers may be used initially when ACE or ARB 
cannot be used but they should be used with caution because of their side 
effects especially in type 1 diabetes mellitus (Lind et al, 1994). Calcium channel 
blockers (CCBs) have no metabolic side effect and they may be useful in 
patients with coronary heart disease (Hansson et al, 1998). Non dihydropyridine 
CCBs may be superior to dihydropyridine CCBs in reducing proteinuria in 
diabetic nephropathy (Bakris et al, 1998). 
Numerous studies show that hypertension is difficult to be controlled in diabetic 
patients. For instance, a study in general medicine clinics found that diabetic 
patients were more likely to have uncontrolled hypertension than did non 
diabetic patients (Hicks et al, 2004). In another study only 25% of diabetics had 
their blood pressure controlled compared to 31% of all hypertensive patients 
(Hajjar and Kotchen 2003).  Another study on a cohort of 1090 diabetic patients 
in primary care clinics reported that hypertension was controlled in 40% of the 
patients surveyed (Duggirala et al, 2005). In a study in a hospital hypertension 
unit in Spain, only 10.5% of diabetic patients had their blood pressure controlled 
compared to 43.5% of those without diabetes (Banegas et al, 2004). A study of 
800 hypertensive male veterans in New England reported that blood pressure 
was less than 140/90 mmHg in only 27% of diabetic persons compared to 34% 
in those without diabetes (Berlowitz et al, 2003). In a cross-sectional study in 
Skara Sweden, diabetic patients were more likely to have uncontrolled diastolic 
blood pressure (DBP) than did non diabetic patients with odds ratio of 2.3(CI 
1.3- 4.1) in men and odds ratio of 3.3(1.9- 5.7) in women (Bog-Hansen et al, 
2003).  
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1.5.5 Hyperlipidemia                                                                                                        
Hyperlipidemia is defined as an elevation of one or more of cholesterol, 
cholesterol esters, phospholipids or triglycerides. Data from Framingham Study 
demonstrate that the risk for developing cardiovascular disease is related to the 
degree of total cholesterol and LDL-C elevation in a graded continuous manner 
(Menotti et al, 1996 and Kannel et al, 1996). Hypertensive patients have a 
greater than expected prevalence of high blood cholesterol levels while 
conversely patients with hypercholesterolemia have a higher than expected 
prevalence of hypertension caused by metabolic syndrome. Treatment of 
hypertension should avoid drugs which can increase cholesterol level, for 
example diuretics and beta-blockers. Drugs of choice are those that do not 
affect lipid levels or those that decrease lipids levels (National, Cholesterol, 
Education, Program, 1994). Hyperlipidemia with or without hypertension is an 
important predictor of cardiovascular disease (Anderson et al, 1998). All 
patients should be advised to keep total dietary intake of fat to ≤ 35% of total 
energy intake, of saturated fats to ≤ 33% of total fat intake, and of cholesterol to 
< 300 mg / day. Treatment with lipid lowering drugs especially statins, has been 
shown to reduce cardiovascular morbidity and mortality in patients with a high 
risk of clinical atherosclerotic disease (Heart Protection Study Collaborative 
Group, 2002). Studies have found that treatment with lipid lowering drugs in 
hypertensive patients with hypercholesterolemia have resulted in a significant 
decrease in blood pressure and this reduction was greater in patients treated 
with statin (Borghi et al, 2004). Furthermore, in a study of 41 hypertensive 
patients with hypercholesterolemia, it was found that the use of statin improved 
blood pressure control (Borghi et al, 2000). In general, patients with 
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hypercholesterolemia and hypertriglyceridemia were found to have poor blood 
pressure control (Alkaja et al, 2003).  Increased level of low density lipoprotein 
is associated with poor blood pressure control (Bizien et al, 2004). In fact, total 
cholesterol of more than 220 mg/dl (5.7mmol/l) was associated with poor blood 
pressure control as noted by a study of hypertensive patients referred to a 
nephrology clinic in Italy (Triolol et al, 2004). In a study in a primary care clinic in 
Sweden,  fasting triglycerides levels of ≥ 1.7 mmol/ l was found to be associated 
with uncontrolled diastolic blood pressure in women (Bøg-Hansen et al, 2003).                         
 
1.5.6 Smoking 
Smoking is associated with hypertension when it is chronic and heavy 
(Primatesta et al, 2001). Blood pressure rise acutely during smoking. In a study 
of 19 smokers with hypertension, blood pressure rose from 140±7/ 99mmHg±3 
to 151±5/108±2mmHg within 10 minutes after smoking. Extensive observation 
data show that smoking has a graded adverse effect on the risk of 
cardiovascular complications (Doll et al, 1994) and smoking increases CVD risk 
more than mild hypertension. It is a major factor related to the persistent 
increase in coronary artery disease and stroke mortality in men with treated 
hypertension (Anderson et al, 1998). Those who stop smoking experience  a 
rapid decline in risk about 50% after 1year but they need about 10 years to 
reach the level of non smokers (Rosenberg et al, 1985). Repeated advice from 
physicians has been shown to decrease smoking by 21% (Law and Tang, 
1995). Nicotine replacement therapies can be safely used in hypertensive 
patients and approximately doubles smoking-cessation rates (Raw et al, 1999). 
One study found that smoking status doesn’t affect blood pressure control but 
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smokers were given a higher dose of antihypertensive to control their blood 
pressure (Buhler et al, 1988). Other study report that there was no difference in 
smoking rates between controlled hypertension and uncontrolled hypertension 
patients (Joshi et al, 1996). The association between smoking and hypertension 
control is not very clear as some studies showed a positive relation, while 
others showed a negative one. Bizien et al (2004) reported good hypertension 
control among smokers and explained that it was because most smokers were 
younger and used diuretics more than non smokers did. Another study in the 
general population of United States showed a low BP control among smokers 
(He and Muntner 2002). In a study conducted in an inner city hospital, it was 
found that African American smokers were more likely to have uncontrolled 
hypertension than did non smokers (McNagny et al, 1997). Additionally, 
hypertension control was found to be lower among smokers (4.4%) compared 
to those who never smoked (8.7%) and those who stopped smoking (14.7) 
(Muntner et al, 2004). 
  
1.5.7 Obesity  
Obesity is defined as an excess of body fat or adipose tissue and is often 
expressed in terms of the body mass index (Lisserner, 1994, Wolf and Colditz 
1998). Individuals with a BMI of >30 kg/m² are considered to be obese 
(Vanltallie, 1994). 
Obese persons have a high risk of developing hypertension and CVD. In a 
cohort of female nurses, it was found that higher body mass index was 
associated with an increased risk of hypertension, and women with a body 
mass index of 31 kg/m² had a multivariate risk of 6.3 compared to women who 
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had body mass index of less than 20 kg/m² (Huang et al, 1998). In fact, 
hypertension prevalence among overweight and obese persons is higher than 
among normal weight persons (Bramlage et al, 2004). Epidemiologic data 
suggest that obesity contributes to the development of hypertension early in life. 
In a school survey of children and adolescents, it was found that mean systolic 
blood pressure increased with an increment in the body mass index 
(Stephenson, 2003). The medical literature has clearly demonstrated that 
obesity is an independent risk for a variety of medical conditions, including 
diabetes mellitus, hypertension, coronary heart disease (CHD) and elevated 
cholesterol levels (Pi-Sunyer, 1996). Although weight reduction by low-calorie 
diets have a modest effect on blood pressure in hypertensive obese patients 
(Conlin et al, 2000 and  Svetkey et al, 1999),  nearly 50% can expect a 
reduction of 5/5 mmHg or better in the short term. The BP lowering effect of 
weight reduction may be enhanced by a simultaneous increase in physical 
exercise (Neter et al, 2003), by alcohol moderation in heavy drinkers (Puddey et 
al, 1992) and by reduction in sodium intake (Whelton et al, 1998).  A study on 
hypertensive patients in Japan showed that a higher body mass index (BMI) 
was associated with lack of systolic hypertension control (Lloyd-Jones et al, 
2000). Besides this, another study showed that highest body mass index was 
associated with poor blood pressure control (Bizien et al, 2004). Finally, another 
study showed that the odds ratio for good control of hypertension was lower in 
overweight patients compared to patients with normal weight (0.6 vs. 0.8) 
(Bramlage et al, 2004).   
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1.5.8 Sodium intake 
Some people are highly sensitive to sodium and this sensitivity can lead to an 
increase in body fluids leading to an increase in blood pressure. Taking more 
sodium than needed may increase the blood pressure. In the Dietary Approach 
to Stop Hypertension (DASH) trial, participants were fed meals with varying salt 
levels for more than 4 weeks. For both DASH and traditional diets, the lower the 
salt intake the lower was the blood pressure (Sacks et al, 2002). Salt reduction 
from an average of 10 to 5g daily lowers BP by about 5/2 mmHg (Whelton et al, 
1998) with larger BP falls in the elderly and those with higher initial BP levels 
(Midgley et al, 1996). Moderate sodium restriction can potentiate the 
hypertensive effect of many antihypertensive medications (MacGregor et al, 
1987). While low sodium diet enhances the antiproteinuric effect of 
antihypertensive especially ACEIs and ARBs (Houlihan et al   2002, Bakris and 
Smith 1996). Data from the Third National Health and Nutrition Examination 
Survey showed that sodium reduction is associated with adequately controlled 
hypertension (He et al, 2002).  This is consistent with the result from a study in 
China in which salt reduction was associated with hypertension control with an 
odds ratio of 1.69 (Muntner et al, 2004). This was proven by a study of 114 
hypertensive patients in Nigeria which showed that in hypertensive men, the 
higher the salt intake the higher the blood pressure (Olubodun et al, 1997).                              
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1.5.9 Alcohol consumption  
Alcohol intake above 21 unit / week is associated with BP elevation (Hart et al, 
1999 and Thun et al, 1997) which is reversible by reducing the intake (Puddey 
et al, 1992 and Maheswaran et al, 1992). Hypertensive patients should be 
advised to limit their alcohol intake to 21 units/week for men and 14 units /week 
for women (William et al, British Hypertension Society Guidelines, 2004). 
Structured interventions to reduce alcohol consumption have on average a 
small effect on BP, reducing SBP by about 3 mmHg. In fact, consumption of 
smaller amounts of alcohol, to the recommended limits, may protect against 
coronary heart disease (Power et al, 1998).  
Alcohol affects hypertension control negatively, this observation was noted in a 
cross sectional study conducted in Yijing area of Anhui Province in China. It 
was found that men who drink Chinese liquor (contain 60% alcohol) had higher 
systolic and diastolic blood pressure than non drinkers (Xu et al, 1997). Another 
study in China reported that individuals who take equal to or more than two 
drinks per day were less likely to have controlled blood pressure and that a 
reduction of alcohol intake was associated with adequate control of 
hypertension (odds ratio 1.48) (Muntner et al, 2004). Also a cross sectional 
study in primary care in Spain showed that alcohol consumption was associated 
with poor control of hypertension (Banegas et al, 2004).  
                                       
1.5.10 Hyperuricemia                                                                                                
Both animal and human studies have demonstrated that asymptomatic 
hyperuricemia is associated with the development of cardiovascular disease 
and is an independent risk factor for the development of hypertension. 
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Increased uric acid levels in childhood is associated with increased systolic and 
diastolic pressure and this was also shown in an adult follow up study 
conducted in Louisiana USA (Alper and Chen et al, 2005). A part from this, the 
association between blood pressure control and hyperuricemia was also studied 
in Bahrain in 281 hypertensive patients in primary care centre. It was found that 
hypertension was poorly controlled in patients with hyperuricemia (Alkaji et al, 
2003).    
                                                        
1.5.11 Family history                                                                                                  
Patients who develop hypertension before age of 40 years are more likely to 
have a strong family history. In a screening of more than a half million people, 
hypertension prevalence in individuals with a positive family history of 
hypertension was double than that found in individuals with a negative history 
(Stamler et al, 1979). In a survey among rural residences in the Philippine an 
association between hypertension and family history was found (Reyes-Gibby 
and Aday 2000). In a longitudinal study of two samples of 745 subjects (age 
ranging from 4.9- 27.5 years) and 687 subjects (age ranging from 8.2-27.5) in 
Georgia in the United States, it was found that subjects with a positive family 
history of hypertension had higher systolic blood pressure than subjects with a 
negative family history of hypertension (Dekkers et al, 2003). 
 Hypertensive patients with family history of hypertension tend to have poor 
blood pressure control as proven by a study of outpatients in a nephrology clinic 
in Italy which found that a family history of hypertension was associated with 
poor control of hypertension (Triolol et al, 2004).                                                                         
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1.5.12 Physical exercise                                                                                                
Taking a regular aerobic exercise has a small effect on blood pressure as it can 
reduce SBP and DBP by 5-6mmHg (Halbert et al, 2000). In observational 
studies, it was noted that physical exercise exert a strong protective effect 
against cardiovascular mortality and this protection is lost when such exercise is 
discontinued (Sandvik et al, 1993). In fact, experts recommend the performance 
of mild exercise such as walking for 30-60 minutes at least 3 times a week in 
order to lower blood pressure (Halbert et al, 1997). Physical exercise was found 
to be associated with lower systolic and diastolic blood pressure especially in 
women (Xu et al, 1997). In general, physical exercise is associated with 
hypertension control (He et al, 2002). Increasing exercise was found to be 
associated with hypertension control with an odds ratio of 1.66 (Muntner et al, 
2004) while a sedentary life style is associated with poor BP control. The latter 
statement was affirmed by a study in Sweden which found that sedentary life 
style was associated with isolated uncontrolled systolic hypertension (Bøg-
Hansen et al, 2003). Furthermore, another study in Kuwait reported a high 
sedentary rate of 91.7% in uncontrolled hypertensive patients (Al-Mehza et al, 
2004).                                                                                                        
 
1.5.13 Patient compliance 
Non-compliance is defined as the failure of the patients to take medications as 
prescribed by the physician. Many factors can lead to noncompliance like side 
effects and cost of medications, education levels and knowledge about 
hypertension. Compliance play an important role in hypertension control as it 
was found that patient’s non compliance was the main cause of uncontrolled 
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hypertension in many studies, one study in hypertensive patients who received 
treatment at a cardiology clinic in the Government Medical College in India 
showed that 61% of those with uncontrolled hypertension did not comply with 
the prescriptions prescribed. (Joshi et al, 1996).  
Some studies also showed that non compliance was also present among 
patients with controlled hypertension but was generally more among patients 
with uncontrolled hypertension. A case control study of hypertensive patients 
indicated that, the rate of compliance was 67% in patients with controlled 
hypertension compared to 47% in patients with uncontrolled hypertension 
(Ahluwalia et al, 1997). Furthermore, a survey in Japan reported that 
noncompliance was found to be higher in patients with poor control of 
hypertension compared with patients with well controlled hypertension (43% vs. 
32%) (Toyoshima et al, 1997).  
 
1.5.14 Patient’s knowledge and awareness   
Knowledge of individuals about hypertension helps in controlling hypertension, 
because with this knowledge individuals will visit physician more and adhere to 
the prescribed treatment. In an interview of 525 hypertensive patients in three 
heath care centers, poor blood pressure control was found to be associated 
with a lack of knowledge about the target of systolic blood pressure (Knight et 
al, 2001). On the other hand, patient’s knowledge about hypertension was 
found to be associated positively with blood pressure control (Majernick et al, 
2004). Similarly, Muntner et al (2004) reported that Awareness of hypertension 
was found to be associated with hypertension control. In the same vein, another 
study found that patients with low awareness were found to have poor control of 
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hypertension, this  association was especially  found to be clear in patients who 
were 65 years and older, male and those who had not been to see a physician 
in the previous year (Hyman and Pavlic 2002). Another study showed that a 
lack of awareness play an important part in poor blood pressure control (Hajjar 
et al, 2003).  
 
1.5.15 Accessibility to health care                                                                                           
There exist a clear relationship between accessibility to heath care and blood 
pressure control. This is because patients exposed to health facilities tend to 
have controlled blood pressure compared with those without health care (Shea 
et al, 1992). In fact, patients who had a blood pressure measurement during the 
preceding 6 months or 6- 11 months had better BP control. Another study 
showed that measuring BP in the preceding 1-5 years was associated with 
hypertension control (He et al. 2002 and Munter, et al, 2004). Besides this, a 
case control study of hypertensive patients in outpatient clinics reported that a 
regular visit to physician during the last 6 months was significantly associated 
with controlled blood pressure (Ahluwalia et al, 1997). Furthermore, research 
shows that regular visits to the same health provider and having private 
insurance was found to be associated with hypertension control (He et al, 
2002). In contrast, uncontrolled hypertension was found to be more common in 
patients who had no primary care physician and who had no health insurance 
(Saver et al, 1993). Interestingly Paramore et al (2001) found that regular visits 
to physicians were more common among patients with uncontrolled 
hypertension. 
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Access to health care alone is not enough to control hypertension. This 
indicated by a study on patients with uncontrolled hypertension in The United 
States, in which it was found that most of those patients had access to health 
care and frequently visited physicians (Hyman and Pavlik 2000). This seems to 
imply that physician visit without increasing treatment will not control 
hypertension. In a study of older men, it was reported that about 40% of 
patients who had blood pressure of ≥160/90 mm Hg had mean of 6.4± 3.3 
hypertension related visits per year. Treatment was increased only in 6.7% of 
the visits and patients who had more intensive treatment had better blood  
pressure control than those with less intensive form of treatment (Berlowitz et 
al,1998).               
Finally, uncontrolled hypertension leads to an increased use of health resources 
in terms of cost of medication and physician visits. In a study of managed care 
patients with hypertension in New Mexico, it was found that a good relationship 
exists between medication costs and blood pressure levels i.e. the higher the 
blood pressure the higher the cost (Paramore et al, 2001). 
   
1.6 Physician factors 
Physician attitude toward blood pressure reading is an important factor.  The 
Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation and Treatment of High Blood Pressure (JNCVII, 2003) 
recommended   a threshold of 140/90 mmHg to start treatment. Despite this, 
some physicians adopt a higher than 140/90 mmHg (Hyman and Pavlik 2000).                      
In a study of patients with uncontrolled hypertension, the cut off point for 
treatment initiation was a diastolic of more than 95 mmHg for 33% of the 
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physician and a systolic of more than 160 mmHg. In non complicated 
hypertension, 25% of physicians reported that they would not increase 
medication if diastolic was 94 mmHg and 33% would not modify treatment if 
systolic was 158 mmHg. In fact, 41% of physicians said that they were not 
familiar with JNC guidelines (Hyman and Pavlik 2000). 
                                                
Physicians tend to delay starting or changing treatment for many reasons. 
Some believe that diastolic blood pressure is more important than systolic and 
as such concentrate more on diastolic pressure. Some do not change 
medication or start treatment until systolic pressure reaches a certain level. 
Satisfaction with elevated systolic blood pressure is a reason for not intensifying 
treatment according to a study on primary care in Detroit. This study found that 
medication change for uncontrolled hypertension occurred only in 38% of the 
visits. And physicians reported that they would only commence treatment when 
the systolic blood pressure attained 150 mm Hg and diastolic blood pressure 
the value reached 91 mm Hg (Oliveria et al, 2002).   
                                                                              
Besides this increasing hypertension treatment is not done in many patients 
with uncontrolled hypertension. In a study conducted in Japan, it was observed 
that primary care physician increased treatment only in 28% of patients with 
uncontrolled hypertension and the age of physician was found to be negatively 
associated with the increased medication prescribed (Asia et al, 2002). 
 
On the other hand, in some settings physicians seem to follow the national 
guidelines as reported by the authors in a survey of 104 primary care physician 
